Biologics Market To Reach USD 625.6 Million By 2026 | Reports And Data
/
Date11 Oct 2019
Email Print Friendly Share New York, Oct. 10, 2019 (GLOBE NEWSWIRE) — Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle... Read More →
HBT Financial Announces Pricing of Initial Public Offering
/
Date11 Oct 2019
Email Print Friendly Share BLOOMINGTON, Ill., Oct. 10, 2019 (GLOBE NEWSWIRE) — HBT Financial, Inc. (“HBT”), the holding company for Heartland Bank and Trust Company... Read More →
Parkland Fuel Corporation Announces October 2019 Dividend
/
Date11 Oct 2019
Email Print Friendly Share CALGARY, Alberta, Oct. 10, 2019 (GLOBE NEWSWIRE) — Parkland Fuel Corporation (“Parkland”) (TSX:PKI) announces that a dividend of $0.0995 per share... Read More →
Velan Inc. Reports Its Second Quarter 2019/20 Financial Results
/
Date11 Oct 2019
Email Print Friendly Share MONTREAL, Oct. 10, 2019 (GLOBE NEWSWIRE) — Velan Inc. (TSX: VLN) (the “Company”), a world-leading manufacturer of industrial valves, announced today... Read More →
Euro Sun Completes Acquisition of All Outstanding Shares of Vilhelmina Minerals Inc.
/
Date11 Oct 2019
Email Print Friendly Share TORONTO, Oct. 10, 2019 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to... Read More →
United Way of New York City, in partnership with CHASE, Announces “March United for Public Schools” for Sunday, October 13th
/
Date11 Oct 2019
Email Print Friendly Share New York, NY, Oct. 10, 2019 (GLOBE NEWSWIRE) — United Way of New York City announces the “March United for Public... Read More →
Highly Accurate SMRT Sequencing for Human Genetics to Be Showcased at ASHG 2019 Annual Meeting
/
Date11 Oct 2019
Email Print Friendly Share MENLO PARK, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing... Read More →
New Head-to-Head Data Show TALTZ® (ixekizumab) Superiority versus TREMFYA® (guselkumab) in People with Moderate to Severe Plaque Psoriasis
/
Date11 Oct 2019
Email Print Friendly Share TALTZ met the primary endpoint of the IXORA-R study, with 41.3 percent of patients taking TALTZ achieving complete skin clearance as... Read More →
Vir Biotechnology Announces Pricing of Initial Public Offering
/
Date11 Oct 2019
Email Print Friendly Share SAN FRANCISCO, Oct. 10, 2019 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage immunology company focused on combining immunologic... Read More →